Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/29/08
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/30/05
End: 01/31/08
Due: 01/31/09
Phase: N/A
Priority: Normal
Start: 07/31/06
End: 11/30/07
Due: 11/30/08
Phase: N/A
Priority: Normal
Start: 09/30/08
End: 04/30/09
Due: 04/30/10
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Phase I Safety and Pharmacokinetic Study of VGX-1027 in Healthy Subjects | NCT00627120 | VGX Pharmaceuticals, LLC | user2@example.com | None | 2008-02-29 | - | - | - | - | 2025-07-14 |
| Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients | NCT00255177 | VGX Pharmaceuticals, LLC | user2@example.com | None | 2005-11-30 | 2008-01-31 | 2009-01-31 | - | - | 2025-07-14 |
| Antiviral Activity and Safety of Mifepristone at 2 Doses in HIV-1 Infected Subjects | NCT00352911 | VGX Pharmaceuticals, LLC | user2@example.com | None | 2006-07-31 | 2007-11-30 | 2008-11-30 | - | - | 2025-07-14 |
| Multiple-Dose Study of VGX-1027 in Healthy Subjects | NCT00760396 | VGX Pharmaceuticals, LLC | user2@example.com | None | 2008-09-30 | 2009-04-30 | 2010-04-30 | - | - | 2025-07-14 |